mRNA vaccines produce more COVID-19 antibodies than AstraZeneca, study finds
CA, 24 Jun 2021
Initial results from a new Canadian study are reinforcing the importance of getting that second COVID-19 vaccine shot — particularly if the first dose was AstraZeneca.
The study, which was supported by the federal government, found a single dose of either the Pfizer-BioNTech or Moderna vaccine produced short-term antibody levels more than one-and-a-half times greater than those produced by one dose of AstraZeneca.
As Jamie Mauracher reports, the findings add urgency to efforts to get second COVID-19 vaccine doses into arms as quickly as possible.
For more info, please go to https://globalnews.ca/news/7972729/covid-antibody-study-canada-vaccine/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews
The study, which was supported by the federal government, found a single dose of either the Pfizer-BioNTech or Moderna vaccine produced short-term antibody levels more than one-and-a-half times greater than those produced by one dose of AstraZeneca.
As Jamie Mauracher reports, the findings add urgency to efforts to get second COVID-19 vaccine doses into arms as quickly as possible.
For more info, please go to https://globalnews.ca/news/7972729/covid-antibody-study-canada-vaccine/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews
